MCID: HYP090
MIFTS: 50

Hyperalphalipoproteinemia malady

Genetic diseases, Metabolic diseases, Endocrine diseases, Rare diseases categories

Summaries for Hyperalphalipoproteinemia

About this section


MalaCards based summary: Hyperalphalipoproteinemia, also known as cholesteryl ester transfer protein deficiency, is related to hypertriglyceridemia and hypoalphalipoproteinemia, and has symptoms including autosomal dominant inheritanceand hyperalphalipoproteinemia. An important gene associated with Hyperalphalipoproteinemia is CETP (cholesteryl ester transfer protein, plasma), and among its related pathways are SREBF and miR33 in cholesterol and lipid homeostasis and Cholesterol and Sphingolipids transport Recycling to plasma membrane in lung normal and CF . The compounds psyllium and p-opc have been mentioned in the context of this disorder. Related mouse phenotypes are endocrine/exocrine gland and liver/biliary system.

Description from OMIM:45 143470

Aliases & Classifications for Hyperalphalipoproteinemia

About this section
Sources:
45OMIM, 10diseasecard, 43Novoseek, 47Orphanet, 22GTR, 60UMLS, 26ICD10 via Orphanet
See all sources

Hyperalphalipoproteinemia, Aliases & Descriptions:

Name: Hyperalphalipoproteinemia 45 10 43 22
Cholesteryl Ester Transfer Protein Deficiency 60
Cholesterol-Ester Transfer Protein Deficiency 47
 
Familial Hyperalphalipoproteinemia 47
Hyperalphalipoproteinemia 1 60
Cept Deficiency 47


Classifications:



External Ids:

OMIM45 143470
Orphanet47 79506
ICD10 via Orphanet26 E78.4

Related Diseases for Hyperalphalipoproteinemia

About this section

Diseases in the Hyperalphalipoproteinemia family:

Cetp-Related Hyperalphalipoproteinemia

Diseases related to Hyperalphalipoproteinemia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 65)
idRelated DiseaseScoreTop Affiliating Genes
1hypertriglyceridemia30.0APOC3, APOB, LPL
2hypoalphalipoproteinemia28.2LCAT, PLTP, LPL, CETP, LDLR, LIPC
3coronary artery disease27.7LCAT, PLTP, LPL, CETP, LDLR, LIPC
4atherosclerosis27.3CRP, APOA1, SCARB1, ABCA1, APOC3, APOA2
5hepatic lipase deficiency10.5LIPC
6hepatitis10.4
7eye disease10.4CRP
8chylomicron retention disease10.3APOB
9apolipoprotein c-iii deficiency10.3
10cetp-related hyperalphalipoproteinemia10.3
11fish-eye disease10.3APOA1, APOA2, LCAT
12norum disease10.2APOA1, APOA2, LCAT
13alagille syndrome10.2LCAT, APOA1
14hyperlipidemia, familial combined10.2APOA1, APOB
15amyloidosis, familial visceral10.2APOA2, APOA1
16arcus senilis10.1APOA1, APOB, LCAT
17peripheral vascular disease10.1CETP, APOB, APOA1
18hypercholesterolemia, due to ligand-defective apo b10.1APOB, LDLR
19cholestasis10.1LCAT, CETP, LIPC
20secondary amyloidosis10.1APOA1, LCAT, CRP
21hypercholesterolemia, familial10.1CETP, LDLR, APOB
22primary hyperoxaluria10.1LCAT, CETP, LIPC, APOC3
23lipase deficiency, combined10.0LIPC, LPL
24coronary stenosis10.0APOA1, APOB, LIPC, CETP
25multiple symmetrical lipomatosis10.0
26multiple symmetric lipomatosis10.0
27artery disease10.0
28lipomatosis10.0
29nicotine dependence, protection against10.0LDLR, APOB, APOA1
30hypobetalipoproteinemia10.0APOA1, APOB, LDLR, LCAT
31polycystic ovary syndrome9.9APOA1, LIPC, CRP
32hepatoblastoma9.9LDLR, APOB, APOA2, APOA1
33stroke, ischemic9.9APOA1, APOB, CRP
34hypothyroidism9.9CETP, LDLR, LIPC, APOB
35acute myocardial infarction9.9CRP, LCAT, APOB, APOA1
36diabetes mellitus, insulin-dependent9.9APOA1, APOB, LIPC, CETP, LCAT
37microvascular complications of diabetes 39.8LIPC, APOB, APOA1
38congenital heart disease9.8APOA1, APOB, LIPC, LDLR, CETP
39amyloidosis9.8APOA1, APOA2, LPL, CRP
40kidney disease9.7APOA1, APOB, LPL, LCAT
41lipodystrophy9.7LPL, LDLR, APOB, APOC3
42arteriosclerosis9.7APOA1, APOB, LDLR, LPL
43abetalipoproteinemia9.7APOA1, APOB, CETP, LPL, LCAT
44nephrotic syndrome9.7APOA1, APOB, CETP, LPL, LCAT
45xanthomatosis9.7ABCA1, APOB, LDLR, LPL
46hypertension, essential9.6APOA1, APOB, LPL, CRP
47cerebrovascular disease9.6APOA1, APOB, LDLR, CETP, LPL
48alzheimer disease9.6ABCA1, APOC3, APOB, LDLR, CETP, PLTP
49proteinuria9.6APOA1, APOC3, APOA2, APOB, CETP, LCAT
50galactosemia9.6APOA1, APOC3, APOB, LIPC, LDLR, CETP

Graphical network of the top 20 diseases related to Hyperalphalipoproteinemia:



Diseases related to hyperalphalipoproteinemia

Symptoms for Hyperalphalipoproteinemia

About this section

Symptoms by clinical synopsis from OMIM:

143470

Clinical features from OMIM:

143470

HPO human phenotypes related to Hyperalphalipoproteinemia:

id Description Frequency HPO Source Accession
1 autosomal dominant inheritance HP:0000006
2 hyperalphalipoproteinemia HP:0012184

Drugs & Therapeutics for Hyperalphalipoproteinemia

About this section

Drug clinical trials:

Search ClinicalTrials for Hyperalphalipoproteinemia

Search NIH Clinical Center for Hyperalphalipoproteinemia

Genetic Tests for Hyperalphalipoproteinemia

About this section

Genetic tests related to Hyperalphalipoproteinemia:

id Genetic test Affiliating Genes
1 Hyperalphalipoproteinemia22

Anatomical Context for Hyperalphalipoproteinemia

About this section

Animal Models for Hyperalphalipoproteinemia or affiliated genes

About this section

MGI Mouse Phenotypes related to Hyperalphalipoproteinemia:

35
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053798.3LCAT, LDLR, LIPC, APOA1, SCARB1, ABCA1
2MP:00053707.1ABCA1, SCARB1, APOA1, APOB, LDLR, LPL
3MP:00053855.9ABCA1, SCARB1, APOA1, APOC3, APOB, LIPG
4MP:00053765.0CRP, ABCA1, SCARB1, APOA1, APOC3, APOA2

Publications for Hyperalphalipoproteinemia

About this section

Articles related to Hyperalphalipoproteinemia:

(show top 50)    (show all 62)
idTitleAuthorsYear
1
Improved plasma cholesterol efflux capacity from human macrophages in patients with hyperalphalipoproteinemia. (24674903)
2014
2
Functional characterization of novel variants in the CETP promoter and the LIPC gene in subjects with hyperalphalipoproteinemia. (23219720)
2013
3
Resequencing CETP, LIPC and LIPG genes in Thai subjects with hyperalphalipoproteinemia. (22464213)
2012
4
Novel mutations of CETP gene in Italian subjects with hyperalphalipoproteinemia. (18926541)
2009
5
Two novel mutations and functional analyses of the CETP and LIPC genes underlying severe hyperalphalipoproteinemia. (19428034)
2009
6
Association of an intronic haplotype of the LIPC gene with hyperalphalipoproteinemia in two independent populations. (18160998)
2008
7
Genetic variation in phospholipid transfer protein modulates lipoprotein profiles in hyperalphalipoproteinemia. (19013296)
2008
8
Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians. (17192423)
2007
9
The two novel CETP mutations Gln87X and Gln165X in a compound heterozygous state are associated with marked hyperalphalipoproteinemia and absence of significant coronary artery disease. (16855848)
2006
10
Cholesteryl ester transfer protein gene mutations in Brazilian hyperalphalipoproteinemia. (16650090)
2006
11
Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties. (14739123)
2004
12
Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia. (12482565)
2003
13
Distribution of human plasma PLTP mass and activity in hypo- and hyperalphalipoproteinemia. (12177167)
2002
14
A novel mutation in the intron 1 splice donor site of the cholesterol ester transfer protein (CETP) gene as a cause of hyperalphalipoproteinemia. (11887180)
2002
15
The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice. (10669644)
2000
16
Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia. (10998455)
2000
17
Elevated hepatic apolipoprotein A-I transcription is associated with diet-induced hyperalphalipoproteinemia in rabbits. (10809165)
2000
18
Mutations of the human hepatic lipase gene in patients with combined hypertriglyceridemia/hyperalphalipoproteinemia and in patients with familial combined hyperlipidemia. (10606208)
1999
19
Hyperalphalipoproteinemia: characterization of a cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activity. (9711993)
1998
20
Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels. (9555865)
1998
21
Upregulated synthesis of both apolipoprotein A-I and apolipoprotein B in familial hyperalphalipoproteinemia and hyperbetalipoproteinemia. (9751249)
1998
22
Hyperalphalipoproteinemia and prostaglandin I2 stability. (9336872)
1997
23
Serum apolipoprotein E-rich HDL-C levels in the subjects with hyperalphalipoproteinemia]. (9311266)
1997
24
Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. (9194754)
1997
25
Cholesteryl ester transfer protein (CETP) deficiency and increased HDL cholesterol levels (hyperalphalipoproteinemia)]. (8847813)
1996
26
Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. (7583564)
1995
27
Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice. (7744879)
1995
28
Unsaturated fatty acids incorporated in HDL in hypo- and hyperalphalipoproteinemia--relation to the HDL-cholesterol level. (7778503)
1994
29
Increased production of apolipoprotein A-I associated with elevated plasma levels of high-density lipoproteins, apolipoprotein A-I, and lipoprotein A-I in a patient with familial hyperalphalipoproteinemia. (8231838)
1993
30
Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population--relation between the mutation and hyperalphalipoproteinemia. (8318066)
1993
31
Rapid detection and prevalence of cholesteryl ester transfer protein deficiency caused by an intron 14 splicing defect in hyperalphalipoproteinemia. (8454281)
1993
32
Compound heterozygote of cholesteryl-ester transfer protein deficiency in a patient with hyperalphalipoproteinemia. (1418105)
1992
33
Association of a polymorphism in the Apo AI gene promoter with hyperalphalipoproteinemia. (1505654)
1992
34
Apolipoprotein C-III(Lys-58-->Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia. (2022742)
1991
35
A family of homozygous familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity. (2360880)
1990
36
Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia. (1980685)
1990
37
High density lipoprotein metabolism in a rabbit model of hyperalphalipoproteinemia. (2920068)
1989
38
Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. (2504859)
1989
39
Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity. (3355618)
1988
40
Decreased serum cholesteryl-ester transfer activity in a patient with familial hyperalphalipoproteinemia. (3193660)
1988
41
Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: implications for atherogenic risk. (3303510)
1987
42
High density lipoproteins with poor reactivity to cholesteryl ester transfer reaction observed in a homozygote of familial hyperalphalipoproteinemia. (3789924)
1986
43
A pedigree of homozygous familial hyperalphalipoproteinemia. (6738363)
1984
44
Metabolic abnormalities in multiple symmetric lipomatosis: elevated lipoprotein lipase activity in adipose tissue with hyperalphalipoproteinemia. (6875381)
1983
45
Complex segregation analysis of hyperalphalipoproteinemia. (7078431)
1982
46
Hyperalphalipoproteinemia, birth to age to years. (7208170)
1981
47
Hyperalphalipoproteinemia in hypercholesterolemic adults and children. (7245576)
1980
48
Neonatal familial hyperalphalipoproteinemia. (191726)
1977
49
Composition of HDL-2 and HDL-3 in familial hyperalphalipoproteinemia. (186077)
1976
50
Familial hyperalphalipoproteinemia. (168823)
1975

Variations for Hyperalphalipoproteinemia

About this section

UniProtKB/Swiss-Prot genetic disease variations for Hyperalphalipoproteinemia:

62
id Symbol AA change Variation ID SNP ID
1CETPp.Asp459GlyVAR_004172rs2303790
2CETPp.Leu168ProVAR_033099
3CETPp.Arg299CysVAR_033100

Clinvar genetic disease variations for Hyperalphalipoproteinemia:

6
id Gene Variation Type Significance SNP ID Assembly Location
1CETPCETP, IVS14DS, G-A, +1single nucleotide variantPathogenic
2CETPNM_000078.2(CETP): c.1376A> G (p.Asp459Gly)single nucleotide variantPathogenicrs2303790GRCh37Chr 16, 57017292: 57017292
3CETPCETP, 1-BP INS, T, IVS14, +3insertionPathogenic

Expression for genes affiliated with Hyperalphalipoproteinemia

About this section
Search GEO for disease gene expression data for Hyperalphalipoproteinemia.

Pathways for genes affiliated with Hyperalphalipoproteinemia

About this section

Pathways related to Hyperalphalipoproteinemia according to GeneCards Suite gene sharing:

(show all 19)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.6ABCA1, LDLR
29.5APOA1, APOA2, ABCA1
3
Show member pathways
Vitamin B12 Metabolism36
9.5SCARB1, APOA1, ABCA1
49.5LIPG, LIPC
5
Show member pathways
9.4APOA1, APOB, SCARB1
69.4SCARB1, APOA1, APOB
7
Show member pathways
9.0SCARB1, APOA1, ABCA1, APOB
8
Show member pathways
8.9SCARB1, LPL, LDLR
9
Show member pathways
8.7LPL, ABCA1, APOA1, APOA2
10
Show member pathways
8.7LPL, LIPC, LIPG
11
Show member pathways
fatty acid beta-oxidation VI (peroxisome)36
8.5LPL, APOA2, APOC3, PLTP, APOA1
12
Show member pathways
thioredoxin pathway36
8.0LDLR, APOB, APOA1, SCARB1, CRP, ABCA1
13
Show member pathways
7.9LPL, LDLR, APOB, APOC3, APOA1, APOA2
147.9APOA1, APOA2, LPL, APOC3, LDLR, APOB
15
Show member pathways
7.9APOC3, LPL, LDLR, APOB, APOA2, APOA1
16
Show member pathways
5.9ABCA1, APOB, SCARB1, APOA1, APOC3, APOA2
17
Show member pathways
5.9LIPC, APOA2, APOC3, APOA1, SCARB1, LDLR
18
Show member pathways
5.3LPL, CETP, LDLR, LIPG, APOB, APOA2

Compounds for genes affiliated with Hyperalphalipoproteinemia

About this section

Compounds related to Hyperalphalipoproteinemia according to GeneCards Suite gene sharing:

(show top 50)    (show all 1308)
idCompoundScoreTop Affiliating Genes
1psyllium439.2LCAT, CETP, APOB, LDLR
2p-opc439.1APOA2, LIPG, APOA1, LCAT, CETP
3cholestyramine439.0LDLR, APOC3, APOB, CETP
4mspi438.8APOA2, APOB, LDLR, CETP, APOC3, APOA1
5fenofibric acid43 289.7APOB, APOC3, APOA1, LPL
6sele438.6LPL, CETP, LDLR, APOC3
7rosuvastatin43 49 28 1211.6APOC3, CETP, CRP, LDLR, APOB, APOA1
8taurocholate438.5LPL, APOB, APOC3, SCARB1, APOA1
9xbai438.5LPL, CETP, LDLR, APOB, APOC3
10lycopene43 249.4LDLR, LPL, CETP, SCARB1, CRP
11tocopherol438.4LDLR, APOB, APOA1, SCARB1, LPL
12carbohydrates438.2LPL, CETP, LDLR, LIPC, APOC3, SCARB1
13ezetimibe43 129.2CETP, CRP, LDLR, APOB, APOA1, ABCA1
14dextran sulfate438.2CETP, PLTP, LPL, LDLR, APOB, APOA1
15ciprofibrate43 289.1APOA1, LPL, LDLR, APOB
16palmitate438.1LPL, LDLR, CETP, APOB, APOA1, LCAT
17betacarotene438.1CRP, LPL, CETP, APOB, SCARB1
18aspirin43 49 28 2411.0LDLR, CRP, CETP, ABCA1, SCARB1, APOB
19fibrinogen438.0ABCA1, LIPC, APOB, APOA2, APOC3, APOA1
20sterol438.0SCARB1, APOA1, APOB, LIPC, LDLR, CETP
21fluvastatin43 49 28 1211.0CETP, CRP, LPL, APOB, APOA1, LDLR
22lovastatin43 49 59 28 1211.9APOA1, LPL, LDLR, APOB, APOC3, LIPC
23thyroxine43 248.9APOB, APOA1, CETP, LPL, LDLR, LIPC
24niacin43 128.9ABCA1, SCARB1, APOB, LDLR, CETP, LPL
25stearic acid43 24 129.9LPL, CETP, LIPC, ABCA1, LDLR, LIPG
26rosiglitazone28 43 49 24 1211.8SCARB1, APOC3, CRP, LPL, ABCA1, APOB
27intralipid437.8APOA1, APOC3, APOA2, APOB, LIPC, CETP
28gemfibrozil28 43 129.7APOB, LIPC, LDLR, CETP, LPL, APOA1
29oleic acid43 28 24 1210.7LIPC, LDLR, PLTP, CETP, LPL, ABCA1
30pioglitazone28 43 49 1210.6CRP, LIPC, APOB, APOA1, SCARB1, ABCA1
31alanine437.1CETP, CRP, SCARB1, PLTP, APOB, LDLR
32pravastatin43 49 28 24 1211.1ABCA1, APOA1, APOC3, APOB, LDLR, CETP
33estrogen437.0LCAT, LPL, APOA1, CETP, LDLR, LIPC
34heparin43 28 24 1210.0LCAT, APOA2, APOC3, APOB, LIPC, LIPG
35probucol43 127.8LCAT, PLTP, LPL, CETP, ABCA1, SCARB1
36vitamin a43 24 128.8APOA1, APOC3, APOB, LIPC, LDLR, CETP
37glucose436.7APOA2, APOB, PLTP, APOC3, APOA1, SCARB1
38simvastatin43 49 59 28 24 1211.7CETP, LPL, PLTP, LCAT, CRP, LDLR
39alpha tocopherol436.7ABCA1, SCARB1, APOA1, APOB, LDLR, CETP
40bezafibrate43 28 128.4ABCA1, APOA1, APOC3, APOA2, APOB, LIPC
41triacylglycerol436.4APOA1, APOC3, APOA2, APOB, LIPG, LIPC
42atorvastatin43 49 28 24 1210.4ABCA1, SCARB1, APOA1, APOC3, APOB, LIPC
43testosterone43 59 24 129.4SCARB1, APOA1, APOC3, APOB, LIPC, LDLR
44cholesterol ester436.3LCAT, PLTP, LPL, CETP, ABCA1, SCARB1
45fenofibrate43 49 128.1ABCA1, SCARB1, APOA1, APOC3, APOA2, APOB
46fatty acid436.0ABCA1, SCARB1, APOC3, APOA2, APOB, LIPG
47phosphatidylcholine435.9ABCA1, LCAT, SCARB1, APOA1, APOA2, APOB
48phospholipid435.7ABCA1, SCARB1, APOA1, APOC3, PLTP, LPL
49lipid435.1APOB, ABCA1, CRP, APOA1, APOC3, APOA2
50cholesterol43 28 24 128.1APOC3, LIPG, LIPC, CRP, LCAT, PLTP

GO Terms for genes affiliated with Hyperalphalipoproteinemia

About this section

Cellular components related to Hyperalphalipoproteinemia according to GeneCards Suite gene sharing:

(show all 11)
idNameGO IDScoreTop Affiliating Genes
1spherical high-density lipoprotein particleGO:00343669.7APOA1, APOC3, APOA2
2intermediate-density lipoprotein particleGO:00343639.7APOC3, APOB
3endocytic vesicle lumenGO:00716829.7APOB, APOA1
4high-density lipoprotein particleGO:00343649.2LCAT, APOA1, APOA2, LIPC, CETP
5low-density lipoprotein particleGO:00343629.2LDLR, APOB
6early endosomeGO:00057698.8APOC3, LDLR, APOA1, APOA2, APOB
7chylomicronGO:00426278.8APOC3, APOA2, APOB, LPL
8very-low-density lipoprotein particleGO:00343618.6APOC3, APOA2, APOB, LPL, APOA1
9cell surfaceGO:00099868.4LPL, ABCA1, SCARB1, LDLR
10extracellular regionGO:00055767.0LCAT, PLTP, LPL, CETP, APOB, APOA2
11extracellular spaceGO:00056156.7APOA1, APOC3, APOB, LIPG, LIPC, CETP

Biological processes related to Hyperalphalipoproteinemia according to GeneCards Suite gene sharing:

(show top 50)    (show all 52)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of cholesterol importGO:006062110.3APOA2, APOC3
2negative regulation of lipase activityGO:006019210.2APOA2, APOA1
3regulation of intestinal cholesterol absorptionGO:003030010.2APOA1, APOA2
4negative regulation of cytokine secretion involved in immune responseGO:000274010.2APOA1, APOA2
5protein oxidationGO:001815810.2APOA1, APOA2
6peptidyl-methionine modificationGO:001820610.2APOA1, APOA2
7positive regulation of cholesterol esterificationGO:001087310.1APOA2, APOA1
8negative regulation of very-low-density lipoprotein particle remodelingGO:001090310.1APOC3, APOA2, APOA1
9chylomicron remnant clearanceGO:003438210.1APOC3, LIPC
10blood vessel endothelial cell migrationGO:004353410.0APOA1, SCARB1
11regulation of phosphatidylcholine catabolic processGO:001089910.0LDLR, SCARB1
12high-density lipoprotein particle clearanceGO:003438410.0APOA1, APOA2, SCARB1
13triglyceride mobilizationGO:000664210.0APOB, APOC3
14negative regulation of lipid catabolic processGO:005099510.0APOC3, APOA2
15phosphatidylcholine biosynthetic processGO:00066569.9APOA2, APOA1, LCAT
16regulation of Cdc42 protein signal transductionGO:00324899.9APOC3, APOA1, ABCA1
17high-density lipoprotein particle assemblyGO:00343809.9APOA1, ABCA1, APOA2
18endothelial cell proliferationGO:00019359.9SCARB1, APOA1
19very-low-density lipoprotein particle assemblyGO:00343799.9APOC3, APOB
20cholesterol importGO:00705089.8SCARB1, LDLR, APOA1
21positive regulation of triglyceride biosynthetic processGO:00108679.8SCARB1, LDLR
22phospholipid transportGO:00159149.8CETP, LDLR, SCARB1
23lipoprotein catabolic processGO:00421599.8APOB, LDLR
24lipoprotein biosynthetic processGO:00421589.7LCAT, APOB, APOA1
25phospholipid effluxGO:00337009.7ABCA1, APOC3, APOA1, APOA2
26negative regulation of macrophage derived foam cell differentiationGO:00107459.7CETP, CRP, ABCA1
27low-density lipoprotein particle clearanceGO:00343839.6LDLR, SCARB1, APOB
28phospholipid catabolic processGO:00093959.5LIPG, APOA2
29low-density lipoprotein particle remodelingGO:00343749.5APOB, APOA2, CETP, LIPC
30lipoprotein transportGO:00429539.4APOB, APOC3
31phospholipid homeostasisGO:00550919.3LIPG, CETP, ABCA1, APOA1
32receptor-mediated endocytosisGO:00068989.3APOB, LDLR, CETP, SCARB1
33triglyceride metabolic processGO:00066419.3APOA2, APOC3, LPL, CETP
34response to nutrientGO:00075849.3LIPG, APOA1, ABCA1, APOC3
35positive regulation of cholesterol storageGO:00108869.2LPL, APOB, SCARB1
36very-low-density lipoprotein particle remodelingGO:00343729.1LIPC, LPL, LCAT, CETP
37lipid metabolic processGO:00066299.1PLTP, LDLR, LIPG
38cholesterol transportGO:00303019.1LCAT, APOB, APOA1, LDLR, CETP
39triglyceride catabolic processGO:00194338.9APOB, APOC3, LPL, LIPC
40cholesterol effluxGO:00333448.9APOB, APOA2, APOC3, APOA1, SCARB1, ABCA1
41response to drugGO:00424938.8ABCA1, LPL, APOA2, APOC3, APOA1
42triglyceride homeostasisGO:00703288.6CETP, LIPC, APOC3, APOA1, SCARB1, LPL
43retinoid metabolic processGO:00015238.3LPL, APOA1, APOC3, APOA2, APOB, LDLR
44phototransduction, visible lightGO:00076038.3APOA1, LDLR, APOB, APOA2, LPL, APOC3
45high-density lipoprotein particle remodelingGO:00343758.2LCAT, CETP, LIPC, LIPG, APOA2, APOC3
46reverse cholesterol transportGO:00436917.8ABCA1, SCARB1, APOA1, LCAT, CETP, LIPC
47cholesterol metabolic processGO:00082037.8ABCA1, APOA1, APOC3, APOA2, APOB, LIPC
48lipoprotein metabolic processGO:00421577.0APOA2, APOB, LDLR, LCAT, LPL, APOC3
49small molecule metabolic processGO:00442817.0CETP, LPL, APOC3, ABCA1, APOB, SCARB1
50cholesterol homeostasisGO:00426326.9LDLR, APOA1, LIPC, LIPG, APOB, APOA2

Molecular functions related to Hyperalphalipoproteinemia according to GeneCards Suite gene sharing:

(show all 20)
idNameGO IDScoreTop Affiliating Genes
1apolipoprotein receptor bindingGO:003419010.0APOA1, APOA2
2phosphatidylcholine-sterol O-acyltransferase activator activityGO:006022810.0APOA1, APOA2
3high-density lipoprotein particle receptor bindingGO:007065310.0APOC3, APOA2, APOA1
4lipase inhibitor activityGO:00551029.9APOA1, APOC3, APOA2
5phosphatidylcholine bindingGO:00312109.9APOA2, CETP
6high-density lipoprotein particle bindingGO:00080359.8APOA1, SCARB1, APOA2
7phospholipid transporter activityGO:00055489.8CETP, APOA1, ABCA1
8apolipoprotein A-I bindingGO:00341869.7LCAT, SCARB1, ABCA1
9lipid transporter activityGO:00053199.7CETP, APOA2
10lipid bindingGO:00082899.6CETP, APOA2, PLTP
11triglyceride bindingGO:00171299.6CETP, LPL
12triglyceride lipase activityGO:00048069.3LIPC, LPL
13lipoprotein lipase activityGO:00044659.2LIPG, LPL
14low-density lipoprotein particle bindingGO:00301699.1LDLR, LIPC, SCARB1, CRP
15cholesterol transporter activityGO:00171279.1APOA2, APOB, CETP, APOA1, ABCA1
16phospholipid bindingGO:00055439.0APOA2, ABCA1, APOA1, APOC3, APOB
17phospholipase activityGO:00046208.9LPL, LIPC, LIPG
18apolipoprotein bindingGO:00341858.9ABCA1, SCARB1, LPL, LIPC
19cholesterol bindingGO:00154858.8ABCA1, CRP, APOA2, APOC3, APOA1, CETP
20heparin bindingGO:00082018.3LIPG, APOB, LIPC, LPL

Products for genes affiliated with Hyperalphalipoproteinemia

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Hyperalphalipoproteinemia

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCIt
39NDF-RT
42NINDS
43Novoseek
45OMIM
46OMIM via Orphanet
50PubMed
51QIAGEN
56SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet